Publications
47
Citations
165
Est. group size
~25
Recurring co-author estimate
Active years
9
Publishing since 2018
Shelby Sloan's research focuses on cancer biology, with recent work examining how specific signaling pathways (such as YAP/TAZ-TEAD) drive tumor stem cell behavior and tumor diversity in pediatric high-grade brain tumors (gliomas). Related work also touches on brain injury in newborns, looking at astrocyte cells (a type of brain support cell) as potential markers or treatment targets. The broader body of work spans topics like lymphoma, gene regulation in cancer, cell signaling pathways, and immune cell therapies such as CAR-T cell treatment.
Publication output has grown markedly, rising from a handful of papers per year in 2017-2020 to a notable surge in 2025 after a period of steady mid-single-digit annual output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- P01.31.A THE YAP/TAZ-TEAD AXIS PROMOTES TUMOR STEM CELL FUNCTIONALITY AND CELLULAR HETEROGENEITY IN PEDIATRIC HIGH-GRADE GLIOMAS
Neuro-Oncology · 2025
- Evaluating astrocyte reactivity as a therapeutic target and diagnostic tool in perinatal brain injury
Zeitschrift für Geburtshilfe und Neonatologie · 2025
- Blood×13
- Blood Advances×3
- PLoS ONE×2
- Cancer Research×2
- Experimental Hematology and Oncology×1
- Mackenzie Long
Medicine · The Ohio State University
- Betsy Pray
Medicine · The Ohio State University
- Carl Quinion
Medicine · The Ohio State University
- Robert A. Baiocchi
Medicine · The Ohio State University
- Lapo Alinari
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile